Lionheart Health, Inc., a leader in bioelectric regenerative medicine and healthspan optimization technologies, has announced that Dr. Joseph C. Maroon, MD, FACS, has joined its Scientific and Clinical Advisory Board. Dr. Maroon is a board-certified neurosurgeon and internationally recognized authority in brain health, sports neurosurgery, concussion management, neuroinflammation, and longevity science.
Dr. Maroon's appointment reinforces Lionheart Health's commitment to advancing evidence-based bioelectric stimulation therapies designed to improve cognition, memory, and mood while supporting neuroplasticity and reducing systemic inflammation. His decades of leadership in neurosurgery and preventive brain health bring exceptional scientific credibility to the company's mission of increasing healthspan through measurable improvements in muscle, brain, and immune function.
The neurosurgeon will advise on brain health clinical study design, neurocognitive endpoint validation, concussion and neuroinflammation applications, and the translation of regenerative signaling science into clinical protocols. Dr. Maroon commented that optimizing brain health is central to extending meaningful healthspan and that he looks forward to supporting Lionheart Health's efforts to scientifically validate innovative bioelectric therapies.
Lionheart Health's intellectual property portfolio includes patents and patent-pending technologies targeting key regenerative and neuroprotective signaling pathways, including Klotho, Brain-Derived Neurotrophic Factor (BDNF), GDF10, SDF-1, PDGF, and eNOS. These pathways are recognized for their roles in neuroplasticity, synaptic resilience, angiogenesis, stem cell homing, endothelial health, and inflammation modulation.
Through its patented bioelectric stimulation platforms, including Brain Band™ and BodStim™, Lionheart Health aims to modulate these regenerative protein expressions to support cognitive performance, memory retention, mood stability, and neurovascular integrity. Brain health represents one of the three core pillars in which Lionheart Health is competing in the Semi-Finals of the $101M XPRIZE Healthspan Competition.
The company's Brain Band™ was recently awarded a prestigious UCI Capstone Grant, providing a multidisciplinary team of five University of California, Irvine engineering PhD-level researchers who worked over a seven-month period to advance device optimization and signal validation. Lionheart Health has also been recognized as 2025 Micro Stimulator Developer of the Year by Medtech Outlook Magazine and won the Abbvie Allergan ULP Innovation Award.
Lionheart Health has completed successful pre-clinical studies at AccuLab Life Sciences in San Diego with grant and credit line support, as well as a successful pilot clinical study in Brazil. The company is preparing to enroll soon in a combination BodStim™ bioelectric stimulation exercise suit and Brain Band™ clinical trial for brain health, with both therapies having separately demonstrated statistically significant improvements in brain health in previous standalone studies.
Dr. Maroon brings more than four decades of leadership in academic neurosurgery, clinical innovation, and performance medicine to the advisory role. He has performed thousands of complex brain and spine procedures and is internationally recognized for advancing minimally invasive neurosurgical techniques. Throughout his tenure at the University of Pittsburgh Medical Center (UPMC), he has helped shape modern standards in concussion management, traumatic brain injury care, and sports-related neurological safety.
As a prolific scientific author with more than 300 peer-reviewed publications and multiple textbooks in neurosurgery, inflammation science, and sports medicine, Dr. Maroon's research has contributed to deeper understanding of neuroinflammation, omega-3 fatty acids in brain protection, performance longevity, and integrative strategies for preserving cognitive function across the lifespan. His unique combination of surgical excellence, scientific rigor, and preventive longevity advocacy aligns directly with Lionheart Health's mission to elevate regenerative signaling and measurable functional performance as central strategies for extending healthy years of life.
